• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP
Click for more information
0.00% 27.0¢

CYNATA THERAPEUTICS LIMITED

Market Cap $48.50M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYP
Ann: Cynata to Acquire IP from Tekcyte 		02/07/24 53 7.1K
02/07/24 Last post  gavint66 Comments Created with Sketch.  53  Views Created with Sketch.  7.1K 
CYP
Ann: Sharewise Investor Presentation 		01/07/24 26 3.5K
01/07/24 Last post  whytegirl Comments Created with Sketch.  26  Views Created with Sketch.  3.5K 
CYP
News: CYP Cynata Therapeutics Ltd Says Co To Acquire Cyp-006Tk Wound Dressing Technology From... 		01/07/24 0 90
01/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  90 
CYP
Ann: Proposed issue of securities - CYP 		01/07/24 0 181
01/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  181 
CYP
The Phase I/IIb Nereid Study Is Now Registered 		30/06/24 20 3.6K
30/06/24 Last post  pfeifer1982 Comments Created with Sketch.  20  Views Created with Sketch.  3.6K 
CYP
Ann: DFU Clinical Trial Enrolment Complete 		28/06/24 33 8.8K
28/06/24 Last post  viewph Comments Created with Sketch.  33  Views Created with Sketch.  8.8K 
CYP
Ann: Investor Presentation
9 10 11
28/06/24 609 105K
28/06/24 Last post  JB1975 Comments Created with Sketch.  609  Views Created with Sketch.  105K 
CYP
Rough thoughts in questions - help yourselves 		26/06/24 1 293
26/06/24 Last post  JB1975 Comments Created with Sketch.  1  Views Created with Sketch.  293 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - CYP
01 Jul 09:51
 
Cynata to Acquire IP from Tekcyte
01 Jul 09:49
 
Sharewise Investor Presentation
27 Jun 09:02
 
CYP Presents at Major International Cell Therapy Conference
29 May 08:38
 
Further GvHD Clinical Data Published in Nature Medicine
22 May 19:10
 
Appendix 3Y-Dr Geoffrey Brooke
17 May 08:26
 
View More arrow Created with Sketch.

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.

(20min delay)
Last
27.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $48.50M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 181 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 13257 2
View Market Depth
Last trade - 07.02am 03/07/2024 (20 minute delay) ?
CYP (ASX) Chart

Top Stories

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Sun Silver executive director Gerard O'Donovan discusses a 6,216 grams Fort Intercept at the Maverick Spring Silver Project from historical data and drill assessments.
ASX Market Open: Bullish Fed comments push ASX200 higher Australian futures are set to rise today on positive US market moves overnight, and bullish comments from the Federal Reserve about rate cuts.
Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25 Uranium was one bright spot at the start of 2024, standing out against otherwise glum markets that defined 2023.
Sun Silver to kick off drilling next week at 292Moz Maverick Springs silver-gold project  The company has locked in a drilling contractor to fire up a Reverse Circulation (RC) drill rig at Maverick starting on 8th of July US time. 
Ark Mines inks 1.5Bt Exploration Target for Sandy Mitchell REE play including NdPr; PFS due in Q4 Ark Mines has published an Exploration Target for its Sandy Mitchell REE project of up to 1.5B tonnes @ up to 1490ppm monazite equivalent

Featured News

BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.